Lantheus (NASDAQ: LNTH) Stock valuation updated by Zacks Investment Research

Lantheus logo

Lantheus (NASDAQ: LNTH) was updated by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released Friday, Zacks.com reports. According to Zacks, “Lantheus Holdings, Inc. is involved in the development, manufacture, sale and distribution of diagnostic imaging agents and products for the diagnosis of cardiovascular and other diseases. It serves … Read more

Zacks Investment Research updates Luxfer (NYSE: LXFR) to keep

Luxfer logo

Luxfer (NYSE: LXFR) was updated by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note released Friday, Zacks.com reports. According to Zacks, “Luxfer Holdings PLC is a materials technology company specializing in the design, manufacture and supply of high performance materials, components and gas cylinders. The company had two … Read more

Heritage Financial (NASDAQ: HFWA) raised to “buy” at Zacks Investment Research

Heritage Financial logo

Financial assets (NASDAQ: HFWA) was updated by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released Friday, Zacks.com reports. The brokerage currently has a price target of $ 29.00 on the financial services provider’s stock. The target price of Zacks Investment Research would indicate a potential upside of 10.35% … Read more

DXP Enterprises (NASDAQ: DXPE) Downgraded by Zacks Investment Research to “Strong Selling”

DXP Enterprises logo

DXP companies (NASDAQ: DXPE) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report released Friday, Zacks.com reports. According to Zacks, “DXP Enterprises, Inc. is a leading distributor of products and services that add value and total cost saving solutions to industrial customers throughout the United States, … Read more

EastGroup (NYSE: EGP) properties were raised for purchase by Zacks Investment Research

EastGroup Properties logo

EastGroup Property (NYSE: EGP) was updated by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note released to investors on Friday, Zacks.com reports. The brokerage currently has a price target of $ 241.00 on the real estate investment fund stock. The Zacks Investment Research target price suggests a potential … Read more

Zacks Investment Research lowers establishment labs (NASDAQ: ESTA) to sell

Establishment Labs logo

Establishment Laboratories (NASDAQ: ESTA) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note released to investors on Friday, Zacks.com reported. According to Zacks, “Establishment Labs Holdings Inc. is a medical technology company. It focuses on the design, development, manufacture and marketing of a portfolio of silicone gel-filled … Read more

UWM (NYSE: UWMC) downgraded to “Hold” at Zacks Investment Research

UWM logo

UWM (NYSE: UWMC) it was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note released to investors on Saturday, Zacks.com reported. According to Zacks, “UWM Holdings Corporation is a parent company of United Wholesale Mortgage. Underwrites and provides closing documentation for residential mortgage loans. UWM Holdings Corporation, formerly … Read more

Yatsen (NYSE: YSG) downgraded to “Hold” at Zacks Investment Research

Yatsen logo

Yatsen (NYSE: YSG) it was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report released Saturday to clients and investors, Zacks.com reports. According to Zacks, “Yatsen Holding Limited is engaged in the development and sale of beauty products. The company offers color cosmetics, eye makeup, lip makeup, … Read more

Zacks Investment Research updates Vascular Biogenesis (NASDAQ: VBLT) to buy

Vascular Biogenics logo

Vascular Biogenics (NASDAQ: VBLT) was updated by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued Saturday to investors, Zacks.com reports. The brokerage currently has a $ 2.25 price target on the biopharmaceutical company’s stock. The target price of Zacks Investment Research would indicate a potential upside of 14.21% … Read more

Zurn Water Solutions (NYSE: ZWS) downgraded by Zacks Investment Research to “hold”

Zurn Water Solutions logo

Zurn Water Solutions (NYSE: ZWS) it was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report released Saturday to clients and investors, Zacks.com reports. According to Zacks, “Zurn Water Solutions Corporation provides a range of advanced water system solutions. The company is engaged in the design, supply, … Read more